These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 29445282)
1. Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness. Omori Y; Kanbayashi T; Imanishi A; Tsutsui K; Sagawa Y; Kikuchi YS; Takeshima M; Yoshizawa K; Uemura S; Shimizu T Neuropsychiatr Dis Treat; 2018; 14():451-457. PubMed ID: 29445282 [TBL] [Abstract][Full Text] [Related]
2. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness. Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547 [TBL] [Abstract][Full Text] [Related]
3. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. Laberge L; Bégin P; Dauvilliers Y; Beaudry M; Laforte M; Jean S; Mathieu J J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):642-6. PubMed ID: 19211594 [TBL] [Abstract][Full Text] [Related]
4. Sleep Disorders in Four Patients With Myotonic Dystrophy Type 1. Urata Y; Nakamura M; Shiokawa N; Yasuniwa A; Takamori N; Imamura K; Hayashi T; Ishizuka T; Kasugai M; Sano A Front Neurol; 2020; 11():12. PubMed ID: 32117000 [TBL] [Abstract][Full Text] [Related]
5. The hypocretin neurotransmission system in myotonic dystrophy type 1. Ciafaloni E; Mignot E; Sansone V; Hilbert JE; Lin L; Lin X; Liu LC; Pigeon WR; Perlis ML; Thornton CA Neurology; 2008 Jan; 70(3):226-30. PubMed ID: 18195268 [TBL] [Abstract][Full Text] [Related]
6. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Nishino S; Kanbayashi T Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155 [TBL] [Abstract][Full Text] [Related]
7. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels. Nakamura M; Kanbayashi T; Sugiura T; Inoue Y J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748 [TBL] [Abstract][Full Text] [Related]
9. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation. Dauvilliers YA; Laberge L Sleep Med Rev; 2012 Dec; 16(6):539-45. PubMed ID: 22465566 [TBL] [Abstract][Full Text] [Related]
10. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503 [TBL] [Abstract][Full Text] [Related]
11. Wanted: a better cut-off value for the Epworth Sleepiness Scale. Trimmel K; Żebrowska M; Böck M; Stefanic A; Mayer D; Klösch G; Auff E; Seidel S Wien Klin Wochenschr; 2018 May; 130(9-10):349-355. PubMed ID: 29340766 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin. Bassetti CL; Baumann CR; Dauvilliers Y; Croyal M; Robert P; Schwartz JC J Sleep Res; 2010 Dec; 19(4):620-3. PubMed ID: 20846244 [TBL] [Abstract][Full Text] [Related]
20. Correlation of Epworth Sleepiness Scale with multiple sleep latency test and its diagnostic accuracy in assessing excessive daytime sleepiness in patients with obstructive sleep apnea hypopnea syndrome. Cai SJ; Chen R; Zhang YL; Xiong KP; Lian YX; Li J; Shen JC; Liu CF Chin Med J (Engl); 2013; 126(17):3245-50. PubMed ID: 24033944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]